Sharish Pharmaceutical Private Limited

Sharish Pharmaceutical Private Limited - pharma in Kadathanamalevillege, Karnataka, India. FY 2026 financials & compliance.
CIN U51909KA2021PTC145039 Incorporated 08 March 2021 ROC Bangalore HQ Kadathanamalevillege, Karnataka, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2022
₹6.91 Lakh
Latest filing
Net loss · FY 2022
₹2.14 Lakh
Net margin -30.9%
EBITDA · FY 2022
-₹2.14 Lakh
EBITDA margin -30.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Sharish Pharmaceutical Private Limited

Data last updated:

Sharish Pharmaceutical Private Limited is a private limited company based in Kadathanamalevillege, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 March 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51909KA2021PTC145039. Its GSTIN is 10ABFCS6569P1ZR (Bihar).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Santosh and Madhu Gupta.

Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at C/O Manish Kumar & Sadhana Kumari Tno B – 4 Tno 203 Sy No 30 34 161, Kadathanamalevillege, Karnataka, India – 560064.

As per the financials filed for FY 2022, the company reported a revenue of ₹6.91 Lakh. For the same year it recorded a net loss of ₹2.14 Lakh (net margin -30.9%) and EBITDA of -₹2.14 Lakh (EBITDA margin -30.9%).

Sharish Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0060755).

Company details

CIN U51909KA2021PTC145039
Registration Number 145039
Incorporation Date 08 March 2021
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0060755

Recognitions & Rankings of Sharish Pharmaceutical

MSME (Udyam registered) Ministry of MSME
Category
Micro (2021-22)
Udyam number
UDYAM-KR-03-0060755

Contact details

Sharish Pharmaceutical Private Limited's registered office is in Kadathanamalevillege, Karnataka. Its e-mail address is in the company report.

  • Email
  • Registered Address
    C/O Manish Kumar & Sadhana Kumari Tno B – 4 Tno 203 Sy No 30 34 161, Kadathanamalevillege, Karnataka, India – 560064
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Sharish Pharmaceutical Private Limited, buy the company report.

Comprehensive company report
Sharish Pharmaceutical Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Sharish Pharmaceutical is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Sharish Pharmaceutical Private Limited, buy the company report.

Financials of Sharish Pharmaceutical Private Limited

FY 2022 filings available

Sharish Pharmaceutical Private Limited reported revenue of ₹6.91 Lakh for FY 2022.

Revenue · FY 2022
₹6.91 Lakh
Net loss · FY 2022
₹2.14 Lakh margin -30.9%
EBITDA · FY 2022
-₹2.14 Lakh margin -30.9%

Financial Statement Summary

MetricsFY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations₹6.91 Lakh
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹2.14 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹2.14 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2021-22FY 2020-21
Profitability
EBITDA Margin-30.9%
Net Profit Margin-30.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Sharish Pharmaceutical Private Limited, buy the company report.

Board of directors of Sharish Pharmaceutical Private Limited

Sharish Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
SantoshDirector08 Mar 20215 Years 7 MonthsCurrent
Madhu GuptaDirector08 Mar 20215 Years 7 MonthsCurrent

Peer comparison

Sharish Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Shreeji Castalloy Private Limited₹6.92 Lakh (FY 2025)-72.0%Vadodara, Gujarat, India
Ren Kissan Samriddhi Producer Company Limited₹6.92 Lakh (FY 2018)547.0%Ajmer, Rajasthan, India
DSD International Private Limited₹6.92 Lakh (FY 2025)72.0%New Delhi, Delhi, India
Sail Through Exim Private Limited₹6.92 Lakh (FY 2025)-84.0%Thiruvalla, Kerala, India
Mangalrashi Marketing Private Limited₹6.92 Lakh (FY 2022)-9.0%Kolkata, West Bengal, India
Sharish Pharmaceutical Private Limitedthis company₹6.91 Lakh (FY 2022)-₹2.14 Lakh-30.9%Kadathanamalevillege, Karnataka, India
Ojaswini Organics Private Limited₹6.91 Lakh (FY 2022)429.0%Delhi, India
Tritec Specialities Private Limited₹6.91 Lakh (FY 2024)-91.0%Navi Mumbai, Maharashtra, India
Matsha Adventure Private Limited₹6.91 Lakh (FY 2020)-8.0%Bangalore, Karnataka, India
Global Dried Flowers Private Limited₹6.91 Lakh (FY 2025)-25.0%Kolkata, West Bengal, India
Eravic Pharmaceuticals Private Limited₹6.91 Lakh (FY 2021)111.0%Lucknow, Uttar Pradesh, India

To see the full peer comparison of Sharish Pharmaceutical Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Sharish Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Sharish Pharmaceutical Private Limited has 1 active EPFO establishment as of Mar 28, 2024.

Active EPFO establishments
1

GST

Sharish Pharmaceutical has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
10ABFCS6569P1ZRBiharActive24 Mar 2021

To see the full GST registrations and return filing status of Sharish Pharmaceutical Private Limited, buy the company report.

Recent activity

Sharish Pharmaceutical Private Limited has 4 board changes on record since 2021: 2 appointments and 2 cessations. The latest: Rishi Kant Singh ceased to be Director on 23 Aug 2021.

AGM
Sharish Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Sharish Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Bangalore.
Ceased
Rishi Kant Singh ceased to be Director.
Ceased
Sharad ceased to be Director.
Appointed
Madhu Gupta was appointed as Director.
Appointed
Santosh was appointed as Director.
Incorporation
08 Mar 2021
Sharish Pharmaceutical Private Limited was registered on 08 Mar 2021 with Roc Bangalore & aged 5 years 7 months as per MCA records.

Frequently asked questions

Sharish Pharmaceutical is an active private limited company based in Kadathanamalevillege, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 March 2021 (5+ years old) and is registered under CIN U51909KA2021PTC145039.

Sharish Pharmaceutical has 2 current directors:

The latest financial statements of Sharish Pharmaceutical on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Sharish Pharmaceutical is 10ABFCS6569P1ZR, registered in Bihar.

The CIN (Corporate Identification Number) of Sharish Pharmaceutical is U51909KA2021PTC145039. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sharish Pharmaceutical was incorporated on 08 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Bangalore.

The peers of Sharish Pharmaceutical by revenue are Shreeji Castalloy Private Limited, Ren Kissan Samriddhi Producer Company Limited, DSD International Private Limited, Sail Through Exim Private Limited, Mangalrashi Marketing Private Limited and 5 more, all in the same principal business activity (wholesale trading).

Rishi Kant Singh ceased to be Director on 23 Aug 2021. Sharad ceased to be Director on 23 Aug 2021. Madhu Gupta was appointed as Director on 08 Mar 2021. Sharish Pharmaceutical has 4 board changes on record in total.

Yes, Sharish Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0060755).

The registered office of Sharish Pharmaceutical is at CO Manish Kumar & Sadhana Kumari Tno B – 4 Tno 203 Sy No 30 34 161, Kadathanamalevillege, Karnataka, India – 560064.

Sharish Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.